Allakos Funding & Investors
San Carlos, CA
Allakos Inc. operates as a clinical stage bio-technology company. The Company discovers and develops therapeutic antibodies for the treatment of allergic, inflammatory, and proliferative diseases. Allakos serves customers in the United States.
allakos.comTotal Amount Raised: $312,449,536
Allakos Funding Rounds
Post Ipo Equity
$150,000,000
Post Ipo Equity Investors
Commodore CapitalVivo CapitalBraidwellRTW InvestmentsDeep Track CapitalNEA - New Enterprise AssociatesLogos Global ManagementTCG Crossover ManagementFrazier Life Sciences ManagementBiotechnology Value FundSurveyor CapitalAlta PartnersIPO
Unknown
Series B
$100,000,000
Series B Investors
NEA - New Enterprise AssociatesRiverVest Venture PartnersPFM Health Sciences3x5 PartnersRoche Venture FundRock Springs CapitalAlta PartnersRedmile GroupSamsara BioCapitalLifeSci Venture PartnersSeries A
$10,000,000
Series A Investors
Novo VenturesAlta PartnersRiverVest Venture PartnersRoche Venture FundSeries A
$24,500,000
Series A Investors
Alta PartnersRiverVest Venture PartnersNovo VenturesRoche Venture FundSeries Unknown
$27,949,545
Funding info provided by Diffbot.